Cancer
Malignant Liver Neoplasm
CI-CAN-00003177Explore in graph →
Top-level908 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003177Explore in graph →
Clinical trials
4,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (459)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00614913 | Proton Beam Therapy for Treatment of Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 76 | Loma Linda UniversityOTHER | 1 | Aug 20, 2012 | clinicaltrials |
| NCT00507585 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin | completed | Phase 1 | 63 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) |
| completed |
| Phase 1 |
| 21 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY |
| 3 |
| Jul 12, 2012 |
| clinicaltrials |
| NCT00999882 | Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients | completed | Phase 1 | 26 | AstraZenecaINDUSTRY | 2 | Jul 10, 2012 | clinicaltrials |
| NCT00731445 | Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 43 | Zeria PharmaceuticalINDUSTRY | 1 | Jul 3, 2012 | clinicaltrials |
| NCT00057980 | Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 8 | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00662246 | Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma | completed | Phase 1 | 24 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00784290 | Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 35 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00030108 | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00036959 | ABT-751 in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 90 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00093444 | Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 2 | Mar 15, 2012 | clinicaltrials |
| NCT00303940 | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | completed | Phase 1 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00988195 | Study of Pegylated Human Recombinant Arginase for Liver Cancer | completed | Phase 1 | 15 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01092091 | Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)(BCT-100-002) | completed | Phase 1 / Phase 2 | 20 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT01131689 | Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 | 20 | Samsung Medical CenterOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01031784 | Radioactive Holmium Microspheres for the Treatment of Liver Metastases(HEPAR) | completed | Phase 1 | 15 | UMC UtrechtOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00073736 | Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 28 | Ligand PharmaceuticalsINDUSTRY | 3 | Aug 12, 2011 | clinicaltrials |
| NCT00882869 | XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 75 | Aegera TherapeuticsINDUSTRY | 1 | Jul 13, 2011 | clinicaltrials |
| NCT00437424 | A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction | completed | Phase 1 | 24 | Bristol-Myers SquibbINDUSTRY | 2 | May 4, 2011 | clinicaltrials |
| NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy(SILIUS) | completed | Phase 1 / Phase 2 | 37 | Kindai UniversityOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT00768937 | Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 22 | Medical University of ViennaOTHER | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00478374 | Sorafenib With TACE to Treat Hepatocellular Carcinoma(S-TACE) | completed | Phase 1 | 21 | University of BernOTHER | 1 | Nov 2, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00230347 | Evaluation of Stereotactic Radiosurgery For Liver Malignancies | completed | Phase 1 | 20 | Stanford UniversityOTHER | 1 | Apr 1, 2010 | clinicaltrials |
| NCT00848094 | Radiation Dose Escalation Study for Advanced Liver Cancer | completed | Phase 1 | 40 | Fudan UniversityOTHER | 0 | Feb 20, 2009 | clinicaltrials |
| NCT00122876 | Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 25 | Light Sciences OncologyINDUSTRY | 3 | Dec 7, 2007 | clinicaltrials |
| NCT00534664 | Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma(TheraBionic) | completed | Phase 1 / Phase 2 | 40 | University of Sao PauloOTHER | 1 | Sep 26, 2007 | clinicaltrials |
| NCT00479050 | Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm(TACE-RFA) | completed | Phase 1 | 291 | Shandong UniversityOTHER | 0 | May 25, 2007 | clinicaltrials |
| NCT00076609 | Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 31 | PhytoCeuticaINDUSTRY | 2 | Mar 28, 2007 | clinicaltrials |
| NCT00234182 | Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC | completed | Phase 1 / Phase 2 | 84 | The University of Hong KongOTHER | 0 | Dec 1, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Aug 20, 2012source: clinicaltrials